Table 5 Number of HES finished consultant episodes with a primary diagnosis of an ADR in 2004/05: mean age of admissions, age & gender distribution of episodes and total bed days
ICD-10 | Male % | Mean age | Age 0–14 (%) | Age 15–59 (%) | Age 60–74 (%) | Age 75+ (%) | Total Bed days | |
|---|---|---|---|---|---|---|---|---|
D59.0/2 | Drug induced haemolytic anaemia | 49 | 63 | 0 (0.0) | 52 (0.5) | 75 (0.8) | 27 (0.3) | 160 |
D61.1 | Drug induced aplastic anaemia | 49 | 64 | 2 (0.0) | 89 (0.9) | 74 (0.7) | 73 (0.7) | 604 |
E03.2 | Hypothyroidism due to medicaments | 42 | 72 | 0 (0.0) | 6 (0.1) | 3 (0.0) | 17 (0.2) | 191 |
E27.3 | Drug induced adrenocortical failure | 41 | 48 | 11 (0.1) | 22 (0.2) | 12 (0.1) | 14 (0.1) | 584 |
F11 | Mental disorders due to opioids | 66 | 32 | 14 (0.1) | 3681 (36.9) | 33 (0.3) | 14 (0.1) | 47390 |
F13 | Mental disorders due to sedatives/hypnotics | 54 | 47 | 6 (0.1) | 123 (1.2) | 33 (0.3) | 27 (0.3) | 4922 |
F19 | Mental disorders due to multiple psychoactive drugs | 75 | 31 | 14 (0.1) | 2734 (27.4) | 17 (0.2) | 10 (0.1) | 64152 |
G21.0 | Malignant neuroleptic syndrome | 67 | 50 | 0 (0.0) | 88 (0.9) | 28 (0.3) | 12 (0.1) | 2,315 |
G21.1 | Drug induced Parkinsonism | 43 | 77 | 1 0.0) | 11 (0.1) | 44 (0.4) | 93 (0.9) | 1,964 |
G24.0 | Drug induced dystonia | 47 | 43 | 10 (0.1) | 65 (0.7) | 16 (0.2) | 18 (0.2) | 550 |
G25.1/4/6 | Drug induced extrapyramidal syndrome/chorea/tics | 40 | 64 | 2 (0.0) | 15 (0.2) | 18 (0.2) | 13 (0.1) | 407 |
G72.0 | Drug induced myopathy | 51 | 65 | 1 (0.0) | 12 (0.1) | 20 (0.2) | 22 (0.2) | 517 |
H91.0 | Ototoxic hearing loss | U/C | U/C | U/C | U/C | U/C | U/C | U/C |
I42.7 | Drug induced cardiomyopathy | 48 | 43 | 7 (0.1) | 42 (0.4) | 7 (0.1) | 5 (0.1) | 376 |
J70.2/3/4 | Drug induced interstitial lung disorders | 49 | 64 | 3 (0.0) | 24 (0.2) | 40 (0.4) | 27 (0.3) | 858 |
K71 | Drug induced liver disease | 43 | 47 | 12 (0.1) | 315 (3.2) | 50 (0.5) | 71 (0.7) | 3408 |
L56.0/1 | Drug induced phototoxicity | 0 | 47 | 1 (0.0) | 2 (0.0) | 2 (0.0) | 0 (0.0) | 17 |
M10.2 | Drug induced gout | 53 | 75 | 0 (0.0) | 4 (0.0) | 9 (0.1) | 21 (0.2) | 237 |
M32.0 | Drug induced systemic lupus erythematosus | 27 | 43 | 0 (0.0) | 19 (0.2) | 2 (0.0) | 5 (0.1) | 69 |
M34.2 | Drug induced systemic sclerosis | U/C | U/C | U/C | U/C | U/C | U/C | U/C |
N14 | Drug induced nephropathy | 2 | 58 | 0 (0.0) | 3 (0.0) | 5 (0.1) | 3 (0.0) | 111 |
T88.3 | Malignant hyperthermia due to anaesthesia | 75 | 20 | 2 (0.0) | 2 (0.0) | 0 (0.0) | 0 (0.0) | 8 |
T88.6 | Drug induced anaphylaxis | 37 | 52 | 19 (0.2) | 326 (3.3) | 130 (1.3) | 87 (0.9) | 883 |
T88.7 | Unspecified adverse drug effect | 33 | 50 | 80 (0.8) | 565 (5.7) | 203 (2.0) | 217 (2.2) | 2,471 |
Total | 33 | 40 | 185 (1.9) | 8200 (82.1) | 821 (8.2) | 776 (7.8) | 132194 |